Company: APM
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001213900-25-111548
Chunk: 44

Company: Aptorum Group Ltd
Filing Date: 2025-11-17
Form: F-1
Chunk 44
---
.S. residents and any of the following three circumstances applies: (1) the majority of the Company’s executive officers or directors are U.S. citizens or residents; (2) more than 50% of its assets are located in the United States; or (3) its business is administered principally in the United States. The Company has taken advantage of certain reduced reporting and other requirements in this prospectus. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold equity securities. In connection with the DiamiR Merger, the Company will transfer by way of continuation to and domesticate as a Delaware corporation and it is anticipated that the Combined Company will not be considered a foreign private issuer. Notes on Prospectus Presentation Numerical figures included in this prospectus have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables may not be arithmetic aggregations of the figures that precede them. Certain market data and other statistical information contained in this prospectus is based on information from independent industry organizations, publications, surveys and forecasts. Some market data and statistical information contained in this prospectus are also based on management’s estimates and calculations, which are derived from our review and interpretation of the independent sources listed above, our internal research and our knowledge of pharmaceutical industry. While we believe such information is reliable, we have not independently verified any third-party information and our internal data has not been verified by any independent source. Accordingly, actual events or circumstances may differ materially from events and circumstances that are assumed in this information and you are cautioned not to give undue weight to such data. Company Corporate Information The Company’s principal executive office is located at 17 Hanover Square, London W1S 1BN, United Kingdom. Its telephone number is +44 20 80929299. The Company’s website is www.aptorumgroup.com. The information on our website is not part of this prospectus. 21

THE OFFERING

| Issuer                                                   |     |                                                                                                                                                         Aptorum Group Limited |
| Shares of Common Stock offered by Selling Securityholder |     |                                                                                                                  Up to 2,060,000 shares of Class A Ordinary Shares consisting 
                                        of: (i) 2,000,000 Class A Ordinary Shares upon exercise of the October 2025 Warrants; and (ii) 60,000 Class A Ordinary Shares issuable 
                                                                                                                                upon exercise of the Placement Agent Warrants. |
| Class A Common Stock outstanding on November 13